These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 25685275)

  • 41. Association of Real-time Continuous Glucose Monitoring With Glycemic Control and Acute Metabolic Events Among Patients With Insulin-Treated Diabetes.
    Karter AJ; Parker MM; Moffet HH; Gilliam LK; Dlott R
    JAMA; 2021 Jun; 325(22):2273-2284. PubMed ID: 34077502
    [TBL] [Abstract][Full Text] [Related]  

  • 42. 1,5-anhydroglucitol as a useful marker for assessing short-term glycemic excursions in type 1 diabetes.
    Seok H; Huh JH; Kim HM; Lee BW; Kang ES; Lee HC; Cha BS
    Diabetes Metab J; 2015 Apr; 39(2):164-70. PubMed ID: 25922811
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inter-day glycemic variability assessed by continuous glucose monitoring in insulin-treated type 2 diabetes patients on hemodialysis.
    Mirani M; Berra C; Finazzi S; Calvetta A; Radaelli MG; Favareto F; Graziani G; Badalamenti S
    Diabetes Technol Ther; 2010 Oct; 12(10):749-53. PubMed ID: 20809678
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Use of Personal Continuous Glucose Monitoring Device Is Associated With Reduced Risk of Hypoglycemia in a 16-Week Clinical Trial of People With Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion.
    Jensen MH; Vestergaard P; Hirsch IB; Hejlesen O
    J Diabetes Sci Technol; 2022 Jan; 16(1):106-112. PubMed ID: 32945187
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Relationship of Hemoglobin A1C to Time-in-Range in Patients with Diabetes.
    Vigersky RA; McMahon C
    Diabetes Technol Ther; 2019 Feb; 21(2):81-85. PubMed ID: 30575414
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of glycemic variability in well-controlled type 2 diabetes mellitus.
    Chon S; Lee YJ; Fraterrigo G; Pozzilli P; Choi MC; Kwon MK; Chin SO; Rhee SY; Oh S; Kim YS; Woo JT
    Diabetes Technol Ther; 2013 Jun; 15(6):455-60. PubMed ID: 23617251
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Alternative biomarkers for assessing glycemic control in diabetes: fructosamine, glycated albumin, and 1,5-anhydroglucitol.
    Lee JE
    Ann Pediatr Endocrinol Metab; 2015 Jun; 20(2):74-8. PubMed ID: 26191510
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Assessing the Therapeutic Utility of Professional Continuous Glucose Monitoring in Type 2 Diabetes Across Various Therapies: A Retrospective Evaluation.
    Kesavadev J; Vigersky R; Shin J; Pillai PBS; Shankar A; Sanal G; Krishnan G; Jothydev S
    Adv Ther; 2017 Aug; 34(8):1918-1927. PubMed ID: 28667580
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Associations between continuous glucose monitoring-derived metrics and arterial stiffness in Japanese patients with type 2 diabetes.
    Wakasugi S; Mita T; Katakami N; Okada Y; Yoshii H; Osonoi T; Kuribayashi N; Taneda Y; Kojima Y; Gosho M; Shimomura I; Watada H
    Cardiovasc Diabetol; 2021 Jan; 20(1):15. PubMed ID: 33413339
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The clinical utility of professional continuous glucose monitoring by pharmacists for patients with type 2 diabetes.
    Ulrich H; Bowen M
    J Am Pharm Assoc (2003); 2021; 61(6):e76-e82. PubMed ID: 34154906
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of Continuous Glucose Monitoring on Hypoglycemia in Older Adults With Type 1 Diabetes: A Randomized Clinical Trial.
    Pratley RE; Kanapka LG; Rickels MR; Ahmann A; Aleppo G; Beck R; Bhargava A; Bode BW; Carlson A; Chaytor NS; Fox DS; Goland R; Hirsch IB; Kruger D; Kudva YC; Levy C; McGill JB; Peters A; Philipson L; Philis-Tsimikas A; Pop-Busui R; Shah VN; Thompson M; Vendrame F; Verdejo A; Weinstock RS; Young L; Miller KM;
    JAMA; 2020 Jun; 323(23):2397-2406. PubMed ID: 32543682
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Real-time continuous glucose monitoring improves glycemic control and reduces hypoglycemia: Real-world data.
    Kant R; Antony MA; Geurkink D; Gilreath N; Chandra L; Zipprer E; Munir KM; Chandra R; Parker VG; Verma V
    Prim Care Diabetes; 2022 Dec; 16(6):786-790. PubMed ID: 36117090
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Continuous Glucose Monitoring: A Brief Review for Primary Care Practitioners.
    Ajjan R; Slattery D; Wright E
    Adv Ther; 2019 Mar; 36(3):579-596. PubMed ID: 30659511
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A systematic review on clinical implication of continuous glucose monitoring in diabetes management.
    Azhar A; Gillani SW; Mohiuddin G; Majeed RA
    J Pharm Bioallied Sci; 2020; 12(2):102-111. PubMed ID: 32742108
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Minimizing Glycemic Fluctuations in Patients with Type 2 Diabetes: Approaches and Importance.
    Dandona P
    Diabetes Technol Ther; 2017 Sep; 19(9):498-506. PubMed ID: 28771387
    [TBL] [Abstract][Full Text] [Related]  

  • 56. International Consensus on Use of Continuous Glucose Monitoring.
    Danne T; Nimri R; Battelino T; Bergenstal RM; Close KL; DeVries JH; Garg S; Heinemann L; Hirsch I; Amiel SA; Beck R; Bosi E; Buckingham B; Cobelli C; Dassau E; Doyle FJ; Heller S; Hovorka R; Jia W; Jones T; Kordonouri O; Kovatchev B; Kowalski A; Laffel L; Maahs D; Murphy HR; Nørgaard K; Parkin CG; Renard E; Saboo B; Scharf M; Tamborlane WV; Weinzimer SA; Phillip M
    Diabetes Care; 2017 Dec; 40(12):1631-1640. PubMed ID: 29162583
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Continuous Glucose Monitoring in Older Adults: What We Know and What We Have Yet to Learn.
    Price C; Callahan KE; Aloi JA; Usoh CO
    J Diabetes Sci Technol; 2024 May; 18(3):577-583. PubMed ID: 38454549
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Glycemic Monitoring and Management in Advanced Chronic Kidney Disease.
    Galindo RJ; Beck RW; Scioscia MF; Umpierrez GE; Tuttle KR
    Endocr Rev; 2020 Oct; 41(5):756-74. PubMed ID: 32455432
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Continuous glucose monitoring and metrics for clinical trials: an international consensus statement.
    Battelino T; Alexander CM; Amiel SA; Arreaza-Rubin G; Beck RW; Bergenstal RM; Buckingham BA; Carroll J; Ceriello A; Chow E; Choudhary P; Close K; Danne T; Dutta S; Gabbay R; Garg S; Heverly J; Hirsch IB; Kader T; Kenney J; Kovatchev B; Laffel L; Maahs D; Mathieu C; Mauricio D; Nimri R; Nishimura R; Scharf M; Del Prato S; Renard E; Rosenstock J; Saboo B; Ueki K; Umpierrez GE; Weinzimer SA; Phillip M
    Lancet Diabetes Endocrinol; 2023 Jan; 11(1):42-57. PubMed ID: 36493795
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Beyond HbA1c and glucose: the role of nontraditional glycemic markers in diabetes diagnosis, prognosis, and management.
    Parrinello CM; Selvin E
    Curr Diab Rep; 2014; 14(11):548. PubMed ID: 25249070
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.